Please assess the completion status of the following clinical trial:

Trial Title: Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Indication of revascularization~* De novo lesions~* Native vessels~* Suitable for stent placement~Exclusion Criteria:~* Acute myocardial infarction within the last 24 hours~* In stent restenosis~* Previous percutaneous coronary intervention within the last 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A--Oral Rapamycin plus BMS (Type: EXPERIMENTAL): Oral sirolimus plus bare metal stent implantation
- B -- Drug Eluting Stent (Type: ACTIVE_COMPARATOR): Drug Eluting Stents

Based on this trial design, predict the completion outcome and termination type (if applicable).